NRCS
NOTICE OF REGISTRATION CONFIRMATION EMAILED
06/16/2026
Back to search
Official data from USPTO
MODULARCMC
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
MODULARCMC
ST13
US500000099256867Class
35, 40, 42
Filing
99256867
Registration
8308283
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
17
Latest update
06/16/2026
Trademark type
Word
Nice classes
35, 40, 42
Filing date
06/27/2025
Registration date
06/16/2026
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
06/16/2026
Last transaction
06/16/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Supplemental Register
Filing basis
Intent to use
First use anywhere
10/25/2024
First use in commerce
10/25/2024
Drawing code
4
Owner type
03
Owner location
Oklahoma City, OK, US
Examiner
KEATING, MICHAEL P
Law office
L10
Current location
TMEG LAW OFFICE 101
Holders and representatives
Holders
Wheeler Bio, Inc.
Representatives
Ava R. Shelby Wilson Sonsini Goodrich & Rosati
Technical classification
Nice Classes
Class 35Class 40Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 35
Business consulting services relating to product distributionoperations management serviceslogisticsreverse logisticssupply chainproduction systems and distribution solutions; Business management servicesmanaging logisticsreverse logisticssupply chain servicessupply chain visibility and synchronizationsupply and demand forecasting and product distribution processes for others; business consulting services in the field of commercialization of pharmaceutical products; distributorship services in the field of pharmaceuticalsbiopharmaceuticalshealth care products and medical products; Invoicing services; Order fulfillment services; customer services in the nature of responding to customer inquiries for others in the field of pharmaceutical product distribution and logistics; inventory control servicescomputerized business record management of pharmaceutical business data; inventory management in the field of pharmaceuticals and pharmaceutical products; computerized tracking and tracing of packages in transit; electronic customer ordering services for pharmaceuticalspharmaceutical productsmedical products and equipmentlaboratory supplies and equipment
Class 40
Manufacture of pharmaceuticals and biopharmaceuticals to the order and specification of others; biomanufacturing for othersmanufacturing of biological products using biological organisms in the manufacturing process for the purpose of facilitating drug development; manufacturing services for others in the fields of mammalian cell line development and therapeutic antibody development; Manufacturing process consulting; contract manufacturing services of biopharmaceuticalsantibodies and recombinant proteins utilizing mammalian cell culture to the order and specification of others; manufacturing services for others in a cGMP (Current Good Manufacturing Practice) compliant facility in the field of pharmaceutical and biopharmaceutical drug development
Class 42
Pharmaceutical and biopharmaceutical drug development services; pharmaceutical and biopharmaceutical research and development; development of pharmaceuticalsbiopharmaceuticalspharmaceutical preparationsmedicinespharmaceutical packaging and drug delivery technologies; research and development of new products for others; product development consultation; product research servicesproviding analytical testingbiosafety testingreporting and laboratory services for others; scientific and technical consulting and research services in the field of pharmaceuticals; consultation in the field of pharmaceutical drug delivery and dosage technologies; custom design and development of chemical reagents and biochemical assays; Biotechnology research; Chemical research; research and development services in the field of antibodies being antibody technology; biotechnology research and development services for othersmammalian cell line development and therapeutic antibody development; development and analysis services relating to the use of mammalian cell cultures in the field of biotechnology; providing medical and scientific technology research information in the field of pharmaceuticals and biopharmaceuticalsincluding discoverypreclinicalclinical drug research and development; toxicological safety testing services for pharmaceuticals and biopharmaceuticals; pharmaceutical contract development in a cGMP (Current Good Manufacturing Practice) compliant facility in the field of pharmaceutical and biopharmaceutical drug development; laboratory testing services in clinical research and clinical trials of innovator medicines in the pharmaceutical and biotechnology fields; ChemistryManufacturingControls (CMC) laboratory and stability testing and analytical services in the fields of pharmaceutical and biopharmaceutical drug development; analytical servicesproviding Good Laboratory Practices (GLP) testing and quality assurance services to assess clinical performance in the field of pharmaceutical and biopharmaceutical drug evaluation and development
Publications
History of USPTO decisions and trademark events.
17 publications found
R.SR
REGISTERED-SUPPLEMENTAL REGISTER
06/16/2026
CNTA
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
05/18/2026
IUAA
USE AMENDMENT ACCEPTED
05/18/2026
AUPC
AMENDMENT TO USE PROCESSING COMPLETE
05/15/2026
IUAF
USE AMENDMENT FILED
05/15/2026
EAAU
TEAS AMENDMENT OF USE RECEIVED
05/15/2026
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
05/15/2026
XELG
APPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
02/04/2026
XELR
APPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
02/04/2026
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
11/18/2025
GNRT
NON-FINAL ACTION E-MAILED
11/18/2025
CNRT
NON-FINAL ACTION WRITTEN
11/18/2025
DOCK
ASSIGNED TO EXAMINER
11/17/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
11/04/2025
MAFR
APPLICATION FILING RECEIPT MAILED
06/27/2025
NWAP
NEW APPLICATION ENTERED
06/27/2025
Continuous trademark protection
Get notified about every new filing that threatens MODULARCMC or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.